This article first appeared on GuruFocus .
Release Date: November 04, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Service revenue grew 4% year-over-year to $59.2 million, driven by pricing actions and installed base expansion.
-
Service gross margin improved 410 basis points to 35.1%, reflecting pricing discipline and cost efficiencies.
-
Operating expenses, excluding restructuring and impairment, decreased 25% year-over-year, demonstrating significant cost reduction.
-
Installed base surpassed 1,100 systems globally, supporting over $230 million in recurring annual revenue.
-
Adjusted EBITDA turned positive at $2.5 million compared to a loss of $4.1 million in the prior year.
Negative Points
-
Total net revenue declined 8% year-over-year to $86.5 million, missing expectations.
-
Product revenue fell 26% year-over-year to $27.3 million, with only 12 units shipped.
-
Product gross orders were $19.8 million, resulting in a book-to-bill ratio of 0.7, below the healthy target of 1.2.
-
Geopolitical and market factors in China significantly impacted product sales performance.
-
Operating income was a loss of $36.5 million, including a $35.4 million non-cash goodwill impairment charge.
Q & A Highlights
Based on the Accuray Incorporated ( NASDAQ:ARAY ) Q1 Fiscal 2027 earnings call transcript, here are the key highlights. Note: The transcript indicates there were no questions during the Q&A session, so these highlights are derived from the prepared remarks of the CEO and CFO.
Q: What were the key drivers and financial results for the first quarter of fiscal 2027? A: CFO Ali Pervaiz reported net revenue of $86.5 million, an 8% decrease year-over-year. This was driven by a 26% decline in product revenue to $27.3 million, which was partially offset by a 4% increase in service revenue to $59.2 million. The company achieved a gross margin of 30.1%, up from 28.8% in the prior year, and adjusted EBITDA was $2.5 million compared to a loss of $4.1 million last year.
Q: What factors contributed to the decline in product revenue and orders? A: CEO Steve Lanive stated that product orders and revenue did not meet expectations, with geopolitical and other market factors in China representing a key headwind. CFO Ali Pervaiz added that product revenue reflected 12 units shipped and that improving commercial execution to drive higher product volumes is a key priority for fiscal 2027.
Q: How is the company's transformation plan impacting its cost structure and profitability? A: CEO Steve Lanive noted that the transformation efforts have significantly exceeded the initial goal of $25 million in annualized profitability improvement from operating cost reductions alone. CFO Ali Pervaiz specified that operating expenses, excluding restructuring and a goodwill impairment, decreased by 25% to $26.8 million, contributing to approximately $13 million of year-over-year bottom-line improvement.
Q: Can you provide an update on the performance of the service business? A: The service business is a key strength, with revenue growing 4% to $59.2 million. CEO Steve Lanive highlighted that the installed base has surpassed 1,100 systems, supporting over $230 million in recurring annual revenue. CFO Ali Pervaiz added that service gross margin improved to 35.1% from 33.9% in the prior year, driven by pricing actions and a lower labor cost structure.
Q: What is the status of the company's financial position and recent financing activities? A: CFO Ali Pervaiz reported that the company received a $15 million cash investment from TCW during the quarter. Following the quarter's end, stockholders approved proposals to advance a transaction that includes exchanging $40 million of term loan debt for convertible preferred equity. This is intended to reduce leverage, enhance liquidity, and provide greater financial flexibility.
Q: What were the details behind the significant GAAP operating loss this quarter? A: CFO Ali Pervaiz explained that the GAAP operating loss of $36.5 million was primarily due to a $35.4 million non-cash goodwill impairment charge. This charge was a result of a gain on debt extinguishment that increased the company's equity without a corresponding increase in fair value. He noted that this non-cash item has no impact on the company's strategic plan or financing agreements.
Q: What are the key strategic initiatives to drive future growth? A: CEO Steve Lanive outlined a focus on strategic partnerships to accelerate innovation. This includes a definitive agreement with RaySearch to advance an online adaptive radiation therapy strategy and a collaboration with Samsung Neurologica to pursue volumetric imaging capabilities for the CyberKnife platform.
Q: What is the current state of the commercial organization and its focus? A: CEO Steve Lanive stated that the company has made significant changes to strengthen its commercial organization, including new leadership, realigned sales and marketing teams, and a dedicated channel management organization. The priority for fiscal 2027 is execution: converting the sizable pipeline into orders and translating those orders into product revenue.
Q: What is the company's outlook and guidance for the remainder of fiscal 2027? A: CFO Ali Pervaiz stated that the company is not providing guidance at this time. However, he emphasized that the team is focused on executing its priorities, maintaining cost discipline, and converting progress into sustainable improvements in profitability and financial performance.
Q: What was the book-to-bill ratio and backlog at the end of the quarter? A: CFO Ali Pervaiz reported that product gross orders for the first quarter were $19.8 million, representing a book-to-bill ratio of 0.7. The trailing 12-month book-to-bill ratio is 1.1. The reported order backlog was approximately $272 million, which includes only orders younger than 30 months.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
